Medicine-Based Evidence in Congenital Heart Disease: How Artificial Intelligence Can Guide Treatment Decisions for Individual Patients
Built on the foundation of the randomized controlled trial (RCT), Evidence Based Medicine (EBM) is at its best when optimizing outcomes for homogeneous cohorts of patients like those participating in an RCT. Its weakness is a failure to resolve a clinical quandary: patients appear for care individua...
Enregistré dans:
Auteurs principaux: | Jef Van den Eynde, Cedric Manlhiot, Alexander Van De Bruaene, Gerhard-Paul Diller, Alejandro F. Frangi, Werner Budts, Shelby Kutty |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4a91857ed8d5485e89f290738d055af5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Left ventricular vortex analysis by high-frame rate blood speckle tracking echocardiography in healthy children and in congenital heart disease
par: Pietro Marchese, et autres
Publié: (2021) -
Pain in adults with congenital heart disease - An international perspective
par: Allison Leibold, et autres
Publié: (2021) -
How to read a published clinical trial: a practical guide for clinicians
par: Mohamad B Sonbol, et autres
Publié: (2020) -
Frequency, Mortality, and Predictors of Adverse Outcomes for Endocarditis in Patients with Congenital Heart Disease: Results of a Nationwide Analysis including 2512 Endocarditis Cases
par: Maarja Maser, et autres
Publié: (2021) -
Trials
Publié: (2006)